Novozymes Receivables 2011-2023 | NVZMY

Novozymes receivables for the quarter ending December 31, 2023 were $0.621B, a 5.27% increase year-over-year.

  • Novozymes receivables for 2023 were $0.621B, a 5.27% increase from 2022.
  • Novozymes receivables for 2022 were $0.59B, a 1.21% decline from 2021.
  • Novozymes receivables for 2021 were $0.597B, a 21% increase from 2020.

Novozymes Receivables 2011-2023 | NVZMY

  • Novozymes receivables for 2023 were $0.621B, a 5.27% increase from 2022.
  • Novozymes receivables for 2022 were $0.59B, a 1.21% decline from 2021.
  • Novozymes receivables for 2021 were $0.597B, a 21% increase from 2020.
Related Stocks
Company NameMarket
Cap
Linde (LIN)$211.4B
Sherwin-Williams (SHW)$94.1B
Ecolab (ECL)$69.2B
PPG Industries (PPG)$28.1B
International Flavors & Fragrances (IFF)$22.7B
Axalta Coating Systems (AXTA)$8.5B
Celanese (CE)$7.9B
CSW Industrials (CSWI)$7B
Element Solutions (ESI)$6.7B
Balchem (BCPC)$5.8B
Arcadium Lithium (ALTM)$5.6B
NewMarket (NEU)$5.1B
Valvoline (VVV)$5B
Nissan Chemical (NNCHY)$4.5B
H B Fuller (FUL)$4B
Ashland (ASH)$3.6B
Sensient Technologies (SXT)$3.2B
Quaker Houghton (KWR)$2.9B
Hawkins (HWKN)$2.6B
Minerals Technologies (MTX)$2.5B
Perimeter Solutions, SA (PRM)$1.9B
Orbia Advance, S.A.B De C.V (MXCHY)$1.7B
Ingevity (NGVT)$1.7B
ELEMENTIS (ELMTY)$1.3B
DAQO New Energy (DQ)$1.2B
Orion S.A (OEC)$1B
Huabao Holdings (HUIHY)$943M
Westlake Chemical Partners LP (WLKP)$796M
AdvanSix (ASIX)$778M
Green Plains (GPRE)$682M